CIK 0001107421 · Non-accelerated filer<br>Smaller reporting company
Alaunos Therapeutics, Inc.
Sign in to watch- Ticker
- TCRT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 841475642
- Phone
- (346) 355-4099
- Business address
- 501 E LAS OLAS BLVD, SUITE 300, FORT LAUDERDALE, FL, 33301
- Former names
- ZIOPHARM ONCOLOGY INC, EASYWEB INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-12-31 | Lafond Kevin G Vice Pres., Treasurer & CAO | Shares withheld for taxes | −9,333 | $4.14 | $39K | 88,534 |
| 2017-12-31 | Cooper Laurence James Neil Chief Executive Officer | Shares withheld for taxes | −16,157 | $4.14 | $67K | 1,389,396 |
| 2017-12-31 | BELBEL CAESAR J COO, CLO, and Secretary | Shares withheld for taxes | −21,667 | $4.14 | $90K | 207,434 |
| 2017-12-30 | WEISER MICHAEL Director | Shares withheld for taxes | −6,021 | $4.14 | $25K | 224,282 |
| 2017-12-30 | LEBEL FRANCOIS Executive Vice President R&D | Shares withheld for taxes | −31,450 | $4.14 | $130K | 222,233 |
| 2017-12-30 | Lafond Kevin G Vice Pres., Treasurer & CAO | Shares withheld for taxes | −13,100 | $4.14 | $54K | 97,867 |
| 2017-12-30 | Fowler Wyche Director | Shares withheld for taxes | −6,882 | $4.14 | $28K | 156,446 |
| 2017-12-30 | Cooper Laurence James Neil Chief Executive Officer | Shares withheld for taxes | −26,178 | $4.14 | $108K | 1,405,553 |
| 2017-12-30 | CANNON JAMES ANTHONY Director | Shares withheld for taxes | −4,301 | $4.14 | $18K | 387,365 |
| 2017-12-30 | BRENNAN MURRAY Director | Shares withheld for taxes | −6,813 | $4.14 | $28K | 72,620 |
| 2017-12-30 | BELBEL CAESAR J COO, CLO, and Secretary | Shares withheld for taxes | −31,450 | $4.14 | $130K | 229,101 |
| 2017-12-29 | WEISER MICHAEL Director | Grant or award | +17,258 | 230,303 | ||
| 2017-12-29 | Tarriff Scott Director | Grant or award · Option Grant (Right to Buy) | +25,000 | 25,000 | ||
| 2017-12-29 | LEBEL FRANCOIS Executive Vice President R&D | Grant or award | +116,000 | 253,683 | ||
| 2017-12-29 | Lafond Kevin G Vice Pres., Treasurer & CAO | Grant or award | +53,000 | 110,967 | ||
| 2017-12-29 | Fowler Wyche Director | Grant or award | +17,258 | 163,328 | ||
| 2017-12-29 | Cooper Laurence James Neil Chief Executive Officer | Grant or award | +348,000 | 1,431,731 | ||
| 2017-12-29 | CANNON JAMES ANTHONY Director | Grant or award | +17,258 | 391,666 | ||
| 2017-12-29 | BRENNAN MURRAY Director | Grant or award | +17,258 | 79,433 | ||
| 2017-12-29 | BELBEL CAESAR J COO, CLO, and Secretary | Grant or award | +87,000 | 260,551 |
Page 12 of 16 · 304 trades